PRKCD and neoplasm: In this study, ROS-induced IL-32β reduced PKCδ-induced apoptosis, however, IL-32β transgenic mice have the increased cytotoxic T lymphocytes and NK cells activity, leads to the inhibition to tumor growth [15].